Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Illegal cannabis use is common among Danes with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Worsening of disability caused by relapses in multiple sclerosis: A different approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. MAIT cell subtypes in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Intoxicationer og ernæringsdeficit

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

View graph of relations

Weighted genetic risk score (wGRS) was analysed for association with disease activity in more than 500 MS patients before and during interferon-beta treatment. The wGRS was higher in MS patients than in healthy controls when analysing eight HLA - and 109 non-HLA MS risk gene variants. No significant associations were observed between number of relapses prior to or during treatment with interferon-beta, both with and without HLA risk alleles included in the wGRS. In conclusion, among Danes the wGRS was higher in MS patients than controls but was not associated with the overall disease activity or response to treatment with interferon-beta.

Original languageEnglish
JournalMultiple Sclerosis and Related Disorders
Volume13
Pages (from-to)25-27
Number of pages3
ISSN2211-0348
DOIs
Publication statusPublished - Apr 2017

    Research areas

  • Adult, Alleles, Female, Genetic Predisposition to Disease, HLA Antigens, Humans, Interferon-beta, Male, Multiple Sclerosis, Polymorphism, Single Nucleotide, Risk Factors, Journal Article

ID: 52217768